Zota Health Care QIP Monitoring Agency Report (Q1 FY27)
Zota Health Care Limited, a healthcare/pharma entity, conducted a Qualified Institutional Placement to raise capital from eligible institutional investors. CRISIL Ratings Limited, appointed as Monitoring Agency, issued a formal report for Q1 FY2026–27 (quarter ended 30 June 2026) detailing how the company has deployed the QIP proceeds. The report is filed with the NSE and serves as evidence of compliance with SEBI's QIP regulations and the company's disclosure obligations to the stock exchange.
Why it mattersThe filing of a Monitoring Agency report by the merchant banker confirms Zota Health Care has successfully raised capital via QIP and is now in the mandatory post-issue compliance and fund-tracking phase under SEBI QIP Regulations; partners should track the quarterly tracking for material deviations from stated use-of-proceeds.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives (Official Exchange Filing) · official
- SEBI ICDR Regulations, 2018 (Official Regulator) · official
- NSE Listing Manual – Disclosure Standards · official
Related deals
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Yatharth Hospital & Trauma Care Services Limited: News Verification28 Aug 2026
- Trilegal acts on Berry Street - Healthify merger27 Aug 2026
- ChrysCapital-backed KIMS in talks to acquire minority stake in Renova Hospitals for $52M25-26 Aug 2026 · $52 million
- Mankind Pharma Limited: Other Restructuring26 Aug 2026
- Mankind Pharma Limited: Outcome of Board Meeting26 Aug 2026